ストックスクリーナーアプリを入手
71.23
1.06%
-0.76
アフターアワーズ：
71.23
Ani Pharmaceuticals Inc (ANIP) 最新ニュース
Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Yahoo Finance
ANI Pharmaceuticals to Present at September Investor Conferences - GlobeNewswire
Corient Private Wealth LP Invests $2.01 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) SVP & CFO Stephen Carey Sells 2,850 S - GuruFocus
Ani Pharmaceuticals SVP & CFO Stephen Carey sells $207,480 in stock - Investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) CFO Stephen Carey Sells 2,850 Shares - MarketBeat
79,683 Shares in ANI Pharmaceuticals, Inc. $ANIP Purchased by Jupiter Topco LLC - MarketBeat
ANI Pharmaceuticals (ANIP) CFO sells 2,850 shares in preset trading plan - Stock Titan
Penn Capital Management Company LLC Boosts Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Man Group plc Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Precision Trading with Ani Pharmaceuticals Inc. (ANIP) Risk Zones - Stock Traders Daily
Freestone Grove Partners LP Takes $8.39 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Sanctuary Advisors LLC Makes New $1.14 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
ANI Pharmaceuticals (ANIP) director reports holding zero shares - Stock Titan
PDT Partners LLC Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
How Investors Are Reacting To ANI Pharmaceuticals (ANIP) Board Shake-Up And Strategic Expertise Addition - simplywall.st
ANI Pharmaceuticals (ANIP) President & CEO Nikhil Lalwani Sells 5,400 Shares - GuruFocus
Ani Pharmaceuticals CEO sells $401,220 in company stock By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals (NASDAQ:ANIP) CEO Sells $401,220.00 in Stock - MarketBeat
ANI Pharmaceuticals (ANIP) CEO sells 5,400 shares under trading plan - Stock Titan
Ani Pharmaceuticals CEO sells $401,220 in company stock - Investing.com
Nikhil Lalwani plans ANI (NASDAQ: ANIP) stock sale topping $400K - Stock Titan
Is ANI Pharmaceuticals (ANIP) Fairly Priced After Its Board Change? - Sahm
ANI Pharmaceuticals adds Henry Gosebruch to board of directors - Investing.com
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors - The Manila Times
Ranger Investment Management L.P. Purchases New Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
William Blair Investment Management LLC Takes $21.37 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (ANIP) Faces A Fresh Valuation Test Following Strong 2026 Results - Sahm
NFJ Investment Group LLC Takes $2.77 Million Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Virtus Advisers LLC Makes New Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Quartz Partners LLC Makes New $1.61 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Great Lakes Advisors LLC Buys Shares of 61,481 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Aurora Investment Counsel Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI (ANIP): Rises 1.37% to $77.92 for the Current Session; Boundary Watch: $74.02 and $81.82 Define the Nearby Reference Levels for the Current SessionHigh Dividend Factor - Vinanet
ANI Pharmaceuticals (NASDAQ:ANIP): What Could Shift Sentiment? - Kalkine Media
Rice Hall James & Associates LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
ANI Pharmaceuticals (ANIP) Q2 2026 Earnings Call Transcript - AOL.com
The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q2 Earnings Call - Yahoo Finance
ANI Pharmaceuticals (ANIP) Could Be 34% Undervalued As Earnings And Guidance Hold - Sahm
Winners And Losers Of Q2: ANI Pharmaceuticals (NASDAQ:ANIP) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Walleye Capital LLC Buys Shares of 106,112 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk? - TradingView
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth - Yahoo Finance
ANI Pharmaceuticals (ANIP) Insider Sell: SR. VP, GENERAL COUNSEL & SEC. Meredith Cook Sells 500 Shares - GuruFocus
ANI Pharmaceuticals Senior VP Meredith Cook Sells 500 Shares via 10b5-1 Trading Plan - Kalkine Media
Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat
ANI Pharmaceuticals (ANIP) counsel Meredith Cook sells 500 shares under 10b5-1 plan - Stock Titan
Amundi Has $352,000 Holdings in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals SVP Ori Gutwerg sells $243,474 in common stock. By Investing.com - Investing.com Australia
Ori Gutwerg Sells 3,162 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat
Ani Pharmaceuticals SVP Ori Gutwerg sells $243,474 in common stock. - Investing.com
ANI Pharmaceuticals (ANIP) SVP, Generics Ori Gutwerg Sells 3,162 Shares - GuruFocus
ANI Pharma SVP, Generics Ori Gutwerg reports sale of 3,162 common shares worth $243,474 - Bitget
ANI Pharmaceuticals (ANIP) SVP Ori Gutwerg sells 3,162 shares at $77 - Stock Titan
ANIP Q2 Deep Dive: Rare Disease Expansion Drives Growth Amid Guidance Recalibration - Yahoo Finance
Analysts cut ANI Pharmaceuticals targets despite Q2 earnings beat - scanx.trade
Guggenheim cuts ANI Pharmaceuticals stock price target on Cortrophin guidance - Investing.com
Canaccord Genuity Group Cuts ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $90.00 - MarketBeat
Canaccord cuts ANI Pharmaceuticals stock price target on Cortrophin miss By Investing.com - Investing.com Canada
1.66%
0.33%
大文字化:
|
ボリューム (24 時間):